Biodesix Inc (BDSX) stock
BDSXNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$8.40−0.48 (-5.41%)
Close on Nov 18, 2026Market cap $88.63MP/E –Yield –
Biodesix net income
Net income is the profit left for shareholders after every expense, interest and tax.
Biodesix's net income for the twelve months ending Jun 30, 2026 was -$27.76M. For fiscal 2025 it was -$35.27M. The highest annual figure on record is -$30.73M in fiscal 2019.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$35.27M | – |
| FY2024 | Dec 31, 2024 | -$42.93M | – |
| FY2023 | Dec 31, 2023 | -$52.15M | – |
| FY2022 | Dec 31, 2022 | -$65.45M | – |
| FY2021 | Dec 31, 2021 | -$43.16M | – |
| FY2020 | Dec 31, 2020 | -$65.45M | – |
| FY2019 | Dec 31, 2019 | -$30.73M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$7.27M | – |
| Q1 FY2026 | Mar 31, 2026 | -$7.79M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.98M | – |
| Q3 FY2025 | Sep 30, 2025 | -$8.72M | – |
| Q2 FY2025 | Jun 30, 2025 | -$11.47M | – |
| Q1 FY2025 | Mar 31, 2025 | -$11.10M | – |
| Q4 FY2024 | Dec 31, 2024 | -$8.25M | – |
| Q3 FY2024 | Sep 30, 2024 | -$10.26M | – |
| Q2 FY2024 | Jun 30, 2024 | -$10.81M | – |
| Q1 FY2024 | Mar 31, 2024 | -$13.61M | – |
| Q4 FY2023 | Dec 31, 2023 | -$9.14M | – |
| Q3 FY2023 | Sep 30, 2023 | -$10.95M | – |
| Q2 FY2023 | Jun 30, 2023 | -$13.36M | – |
| Q1 FY2023 | Mar 31, 2023 | -$18.70M | – |
| Q4 FY2022 | Dec 31, 2022 | -$20.34M | – |
| Q3 FY2022 | Sep 30, 2022 | -$13.70M | – |
| Q2 FY2022 | Jun 30, 2022 | -$15.82M | – |
| Q1 FY2022 | Mar 31, 2022 | -$15.59M | – |
| Q4 FY2021 | Dec 31, 2021 | -$13.28M | – |
| Q3 FY2021 | Sep 30, 2021 | -$11.51M | – |
| Q2 FY2021 | Jun 30, 2021 | -$11.40M | – |
| Q1 FY2021 | Mar 31, 2021 | -$6.96M | – |
| Q4 FY2020 | Dec 31, 2020 | -$38.63M | – |
| Q3 FY2020 | Sep 30, 2020 | -$8.85M | – |
| Q2 FY2020 | Jun 30, 2020 | -$8.27M | – |
| Q1 FY2020 | Mar 31, 2020 | -$9.71M | – |
| Q4 FY2019 | Dec 31, 2019 | -$6.53M | – |
| Q3 FY2019 | Sep 30, 2019 | -$9.60M | – |
| Q2 FY2019 | Jun 30, 2019 | -$6.86M | – |
| Q1 FY2019 | Mar 31, 2019 | -$7.74M | – |
See a number that looks wrong?